Ignite Creation Date:
2025-12-24 @ 1:02 PM
Ignite Modification Date:
2026-02-05 @ 6:49 PM
Study NCT ID:
NCT00016861
Status:
COMPLETED
Last Update Posted:
2013-06-26
First Post:
2001-06-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
Sponsor:
Texas Children's Cancer Center
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
TCCC-H-6957
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None